scispace - formally typeset
G

Gian Luca Salvagno

Researcher at University of Verona

Publications -  428
Citations -  12680

Gian Luca Salvagno is an academic researcher from University of Verona. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 49, co-authored 397 publications receiving 10707 citations. Previous affiliations of Gian Luca Salvagno include University of Milan & Cincinnati Children's Hospital Medical Center.

Papers
More filters
Journal ArticleDOI

Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia.

Massimo Franchini, +7 more
- 01 Apr 2009 - 
TL;DR: Current knowledge is summarized with respect to the modulation of the clinical phenotype of severe hemophilia by prothrombotic genetic risk factors and a protective effect for the coinheritance of factor V Leiden is indicated.
Journal ArticleDOI

The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon

Gian Luca Salvagno, +6 more
- 01 Feb 2014 - 
TL;DR: The results of this study demonstrate that high-intensity endurance exercise is associated with biochemical abnormalities that may reflect adverse consequences on cardiac structure and biology.
Journal ArticleDOI

Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement.

Giuseppe Lippi, +3 more
- 01 May 2009 - 
TL;DR: The most promising approach for dealing with hemolysis in patient samples is based on process monitoring, education and prevention, and effectiveness can only be achieved once the process has been extensively investigated.
Journal ArticleDOI

Influence of acute physical exercise on emerging muscular biomarkers.

Giuseppe Lippi, +4 more
- 01 Sep 2008 - 
TL;DR: It is concluded that a sub-maximal aerobic exercise influences the concentration of several markers of muscle damage, except for IMA, which can be safely used to rule out myocardial damage as well as cardiospecific troponins in patients who had undergone recent physical activity.
Journal ArticleDOI

Hemophilia and cancer: A new challenge for hemophilia centers

Massimo Franchini, +8 more
- 01 Jun 2009 - 
TL;DR: The improved life expectancy of hemophilia patients due to the advances in Hemophilia care and factor replacement therapy has permitted to hemophiliacs to reach an older age, and the management of cancer in people with inherited hemorrhagic disorders represents a new challenge for physicians working in hemophiliary centers.